CD44 and breast carcinoma: 6-Methoxymellein inhibits the proliferation, migration, and colony and mammosphere formation of breast cancer cells and decreases the subpopulation of CD44+/CD24− and the expression of c-Myc, Sox-2 and Oct4 proteins.